Jin Medical International (ZJYL) Cash & Current Investments (2022 - 2025)

Jin Medical International (ZJYL) has reported Cash & Current Investments for 4 consecutive years, with $29.6 million the latest figure, recorded in Q3 2025.

• Quarterly Cash & Current Investments rose 10.74% year-over-year to $29.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $29.6 million (up 10.74% YoY) and the FY2025 annual result came in at $29.6 million, up 10.74% from the prior year.
• Cash & Current Investments declined to $29.6 million in Q3 2025 per ZJYL's latest filing, from $31.0 million in the prior quarter.
• Over the last five years, Cash & Current Investments for ZJYL reached as high as $31.0 million in Q1 2025 and fell as low as $7.1 million in Q3 2022.
• A 4-year average of $21.5 million and a median of $26.0 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2023 — Cash & Current Investments soared 136.23% — and 2025, when it grew 10.74%.
• Year by year, Cash & Current Investments stood at $7.1 million in 2022, then jumped by 136.23% to $16.7 million in 2023, then soared by 60.24% to $26.8 million in 2024, then gained by 10.74% to $29.6 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $29.6 million, $31.0 million, and $26.8 million for Q3 2025, Q1 2025, and Q3 2024 respectively.